Plasma Anti-FXa Level as a Surrogate Marker of the Adequacy of Thromboprophylaxis in Critically Ill Patients: A Systematic Review
Thrombosis Research - United Kingdom
doi 10.1016/j.thromres.2015.12.016
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2016
Authors
Publisher
Elsevier BV